Your browser doesn't support javascript.
loading
Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case.
Santoro, Cristina; Volpicelli, Paola; Baldacci, Erminia; Ferrara, Grazia; Di Rocco, Alice; Ferretti, Antonietta; Porrazzo, Marika; Mazzucconi, Maria Gabriella.
Affiliation
  • Santoro C; Hematology Department of Cellular Biotechnology and Hematology "Sapienza" University of Rome Italy.
  • Volpicelli P; Hematology Department of Cellular Biotechnology and Hematology "Sapienza" University of Rome Italy.
  • Baldacci E; Hematology Department of Cellular Biotechnology and Hematology "Sapienza" University of Rome Italy.
  • Ferrara G; Hematology Department of Cellular Biotechnology and Hematology "Sapienza" University of Rome Italy.
  • Di Rocco A; Hematology Department of Cellular Biotechnology and Hematology "Sapienza" University of Rome Italy.
  • Ferretti A; Hematology Department of Cellular Biotechnology and Hematology "Sapienza" University of Rome Italy.
  • Porrazzo M; Hematology Department of Cellular Biotechnology and Hematology "Sapienza" University of Rome Italy.
  • Mazzucconi MG; Hematology Department of Cellular Biotechnology and Hematology "Sapienza" University of Rome Italy.
Clin Case Rep ; 5(8): 1385-1388, 2017 08.
Article in En | MEDLINE | ID: mdl-28781864
Thrombopoietin receptor agonists (TPO-RAs) are used as effective alternative treatments in ITP patients unresponsive to first-/second-line therapies. TPO-RAs can also be used to normalize platelet count to safely perform invasive procedures and chemotherapy, in case of malignancies. In few responsive patients, TPO-RAs can be suspended maintaining a sustained response.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2017 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Case Rep Year: 2017 Document type: Article Country of publication: